US-Listed Retail-Drug Stores And Proprietary Stores — EBITDA Margin Percentiles, FY 2022
Population: 8 US-listed companies (SIC 5912), fiscal year 2022; fiscal year ends 2022-08-31 to 2023-03-31.
Fiscal year: 2019 · 2020 · 2021 · 2022 · latest
| 10th percentile | -41.2% |
|---|
| 25th percentile | -13.1% |
|---|
| Median | -4.1% |
|---|
| 75th percentile | 2.9% |
|---|
| 90th percentile | 3.8% |
|---|
| Mean | -14.7% |
|---|
| Minimum | -88.0% |
|---|
| Maximum | 3.9% |
|---|
Methodology & sources
EBITDA margin = (operating income + depreciation & amortization) / revenue, all values as filed; computed in SQL per company, then percentiles. Fiscal year 2022 = fiscal years ending 2022-06-01 to 2023-05-31 (majority-overlap rule; June-ending fiscal years count toward the ending calendar year).
Source: SEC EDGAR filings (public domain). Data: FACTANKER registry, precomputed 2026-09-04.
Evidence samples
Latest EBITDA Margin percentiles (live) · All Retail-Drug Stores And Proprietary Stores benchmarks · All industries
Cite as: FACTANKER, https://factanker.com/industries/sic-5912/ebitda-margin/2022